Colin Goodchild
1
Seguidor
Personal Information
Organización/Lugar de trabajo
Malvern, Victoria Australia
Ocupación
Executive Director, Chief Medical Officer
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
wwwdrawbridgepharmaceuticals.com.au
Acerca de
Drawbridge was founded in 2011. It is a privately-held company with headquarters in Melbourne, Australia. Drawbridge is developing neuroactive steroid compounds for use in critical care situations in which protection of the brain from insult is required. Phaxan™ is the lead compound for use as a fast onset and offset intravenous general anaesthetic and sedative that causes neuroprotection.
Etiquetas
procedural sedation
intensive care sedation
intravenous anaesthetic
alphaxalone
anaesthesia
water soluble intravenous anaesthetic
cyclodextrin
therapeutic index
alfaxalone
phaxan
water soluble anaesthetic
anaesthetic
Ver más
- Presentaciones
- Documentos
- Infografías